Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis

被引：0
|
作者：
Ralph Wäsch
Tim Strüssmann
Claudia Wehr
Reinhard Marks
Phillip T. Meyer
Gerd Walz
Monika Engelhardt
机构：
[1] University of Freiburg,Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center
[2] University of Freiburg, University of Freiburg, Faculty of Medicine
[3] University of Freiburg,Department of Nuclear Medicine, Medical Center
来源：
Annals of Hematology | 2023年 / 102卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1269 / 1270
页数：1
相关论文
共 50 条
  • [21] Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
    Kambhampati, Swetha
    Sheng, Ying
    Huang, Chiung-Yu
    Bylsma, Sophia
    Lo, Mimi
    Kennedy, Vanessa
    Natsuhara, Kelsey
    Martin, Thomas
    Wolf, Jeffrey
    Shah, Nina
    Wong, Sandy W.
    BLOOD ADVANCES, 2022, 6 (07) : 2045 - 2054
  • [22] Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma
    Miller, Kevin
    Hashmi, Hamza
    Rajeeve, Sridevi
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [23] CAR T-cell therapy for lymphoma and multiple myeloma
    Kochenderfer, James N.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [24] Toxicity of CAR T-Cell Therapy for Multiple Myeloma
    Afrough, Aimaz
    Abraham, Pearl Rajan
    Turer, Laura
    Kaur, Gurbakhash
    Sannareddy, Aishwarya
    Hansen, Doris K.
    Anderson, Larry D.
    ACTA HAEMATOLOGICA, 2024,
  • [25] Multitargeted CAR T-cell therapy in multiple myeloma
    Adaniya, Sandra Susanibar
    Garfall, Alfred L.
    LANCET HAEMATOLOGY, 2019, 6 (10): : E494 - E495
  • [26] Efficacy and Safety of Fully Human Bcma Targeting CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Li, Chunrui
    Wang, Jue
    Wang, Di
    Hu, Guang
    Yang, Yongkun
    Zhou, Xiaoxi
    Meng, Li
    Hong, Zhenya
    Chen, Liting
    Mao, Xia
    Xiao, Min
    Zhou, Jianfeng
    BLOOD, 2019, 134
  • [27] Monitoring anti-BCMA CAR T-Cell Therapy with bb2121 in relapsed multiple myeloma
    Seipel, K.
    Wiedemann, G.
    Jeker, B.
    Porret, N.
    Taleghani, B. Mansouri
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2021, 151 : 24 - 24
  • [28] Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
    Raje, Noopur
    Berdeja, Jesus
    Lin, Yi
    Siegel, David
    Jagannath, Sundar
    Madduri, Deepu
    Liedtke, Michaela
    Rosenblatt, Jacalyn
    Maus, Marcela V.
    Turka, Ashley
    Lam, Lyh-Ping
    Morgan, Richard A.
    Friedman, Kevin
    Massaro, Monica
    Wang, Julie
    Russotti, Greg
    Yang, Zhihong
    Campbell, Timothy
    Hege, Kristen
    Petrocca, Fabio
    Quigley, M. Travis
    Munshi, Nikhil
    Kochenderfer, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18): : 1726 - 1737
  • [29] Impact of Clonal Hematopoiesis on Clinical Outcomes to BCMA-Directed CAR T-Cell Therapy in Multiple Myeloma
    Gustine, Joshua
    Branagan, Andrew
    Cirstea, Diana
    Rexha, Farah
    Han, Ryan
    Yee, Andrew
    Frigault, Matthew
    Raje, Noopur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S4 - S5
  • [30] Development of KITE-585: A fully human BCMA CAR T-cell therapy for the treatment of multiple myeloma
    Adams, Gregor B.
    Feng, Jun
    Ghogha, Atefah
    Mardiros, Armen
    Murakami, Jodi
    Phung, Tammy
    Rodriguez, Ruben
    Sievers, Stuart
    Spindler, Tassja J.
    Wiltzius, Jed
    Yarka, Clare
    Yoder, Sean C.
    Polverino, Tony
    CANCER RESEARCH, 2017, 77
12345